T Schacker

Summary

Affiliation: University of Minnesota
Country: USA

Publications

  1. ncbi Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection
    T Schacker
    Dept of Medicine Infectious Diseases, University of Minnesota, Box 250 UMHC, 516 Delaware St SE, Minneapolis, MN 55455, USA
    J Infect Dis 183:555-62. 2001
  2. ncbi Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression
    Timothy Schacker
    Department of Medicine, University of Minnesota, Minneapolis, 55455, USA
    J Infect Dis 186:1718-25. 2002
  3. ncbi Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy
    T Schacker
    Department of Medicine Infectious Diseases, University of Minnesota, 216 Delaware St, Minneapolis, MN 55455, USA
    J Infect Dis 181:354-7. 2000
  4. ncbi Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men
    T Schacker
    Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA
    J Infect Dis 178:1616-22. 1998
  5. ncbi The role of HSV in the transmission and progression of HIV
    T Schacker
    Department of Medicine, University of Minnesota, Division of Infectious Diseases, Box 250, 516 Delaware Street, Minneapolis, MN 55055, USA
    Herpes 8:46-9. 2001
  6. ncbi Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS
    M M Berrey
    Department of Medicine, University of Washington, Seattle, WA, USA
    J Infect Dis 183:1466-75. 2001
  7. ncbi Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection
    U Malhotra
    Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    J Infect Dis 181:121-31. 2000
  8. ncbi Amount of lymphatic tissue fibrosis in HIV infection predicts magnitude of HAART-associated change in peripheral CD4 cell count
    Timothy W Schacker
    Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
    AIDS 19:2169-71. 2005
  9. ncbi Abnormal presence of semimature dendritic cells that induce regulatory T cells in HIV-infected subjects
    Mitchell D Krathwohl
    Department of Medicine, University of Minnesota, Minneapolis, USA
    J Infect Dis 193:494-504. 2006
  10. ncbi Lymphatic tissue fibrosis is associated with reduced numbers of naive CD4+ T cells in human immunodeficiency virus type 1 infection
    Timothy W Schacker
    Department of Medicine Infectious Diseases, University of Minnesota, MMC 250, 516 Delaware Street, Minneapolis, MN 55455, USA
    Clin Vaccine Immunol 13:556-60. 2006

Collaborators

Detail Information

Publications22

  1. ncbi Productive infection of T cells in lymphoid tissues during primary and early human immunodeficiency virus infection
    T Schacker
    Dept of Medicine Infectious Diseases, University of Minnesota, Box 250 UMHC, 516 Delaware St SE, Minneapolis, MN 55455, USA
    J Infect Dis 183:555-62. 2001
    ..Despite the relatively high frequency of productively infected cells in LT, the impact on the size of the T cell population in LT at this stage was minor...
  2. ncbi Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression
    Timothy Schacker
    Department of Medicine, University of Minnesota, Minneapolis, 55455, USA
    J Infect Dis 186:1718-25. 2002
    ..These data indicate that frequent mucosal HSV reactivation influences HIV replication in vivo and daily HSV suppression may be important in the management of HSV-positive/HIV-positive persons...
  3. ncbi Rapid accumulation of human immunodeficiency virus (HIV) in lymphatic tissue reservoirs during acute and early HIV infection: implications for timing of antiretroviral therapy
    T Schacker
    Department of Medicine Infectious Diseases, University of Minnesota, 216 Delaware St, Minneapolis, MN 55455, USA
    J Infect Dis 181:354-7. 2000
    ....
  4. ncbi Frequency of symptomatic and asymptomatic herpes simplex virus type 2 reactivations among human immunodeficiency virus-infected men
    T Schacker
    Department of Medicine, University of Minnesota, Minneapolis, MN 55455, USA
    J Infect Dis 178:1616-22. 1998
    ..Thus, subclinical HSV-2 reactivation is an important opportunistic infection in persons with HIV infection. Further studies are necessaryto determine the impact of subclinical HSV-2 reactivation on the natural history of HIV infection...
  5. ncbi The role of HSV in the transmission and progression of HIV
    T Schacker
    Department of Medicine, University of Minnesota, Division of Infectious Diseases, Box 250, 516 Delaware Street, Minneapolis, MN 55055, USA
    Herpes 8:46-9. 2001
    ....
  6. ncbi Treatment of primary human immunodeficiency virus type 1 infection with potent antiretroviral therapy reduces frequency of rapid progression to AIDS
    M M Berrey
    Department of Medicine, University of Washington, Seattle, WA, USA
    J Infect Dis 183:1466-75. 2001
    ..Combination antiretroviral therapy during primary HIV-1 infection demonstrated a decreased frequency of minor opportunistic infections, mucocutaneous disorders, and respiratory infections and reduced progression to AIDS...
  7. ncbi Effect of combination antiretroviral therapy on T-cell immunity in acute human immunodeficiency virus type 1 infection
    U Malhotra
    Department of Medicine, University of Washington, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA
    J Infect Dis 181:121-31. 2000
    ..The amplified HIV-1-specific T-cell responses may help maintain cytotoxic activities...
  8. ncbi Amount of lymphatic tissue fibrosis in HIV infection predicts magnitude of HAART-associated change in peripheral CD4 cell count
    Timothy W Schacker
    Department of Medicine, University of Minnesota, Minneapolis, Minnesota, USA
    AIDS 19:2169-71. 2005
    ..001). This suggests that collagen-targeted therapies might be of benefit...
  9. ncbi Abnormal presence of semimature dendritic cells that induce regulatory T cells in HIV-infected subjects
    Mitchell D Krathwohl
    Department of Medicine, University of Minnesota, Minneapolis, USA
    J Infect Dis 193:494-504. 2006
    ..We conclude that HIV infection correlates with the presence of semimature DCs that stimulate T cell tolerance rather than immunity. These regulatory T cells may contribute to the lack of effective HIV immune responses...
  10. ncbi Lymphatic tissue fibrosis is associated with reduced numbers of naive CD4+ T cells in human immunodeficiency virus type 1 infection
    Timothy W Schacker
    Department of Medicine Infectious Diseases, University of Minnesota, MMC 250, 516 Delaware Street, Minneapolis, MN 55455, USA
    Clin Vaccine Immunol 13:556-60. 2006
    ....
  11. ncbi Microbial translocation is a cause of systemic immune activation in chronic HIV infection
    Jason M Brenchley
    Human Immunology Section, Vaccine Research Center, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA
    Nat Med 12:1365-71. 2006
    ..These data establish a mechanism for chronic immune activation in the context of a compromised gastrointestinal mucosal surface and provide new directions for therapeutic interventions that modify the consequences of acute HIV infection...
  12. ncbi Potential roles of follicular dendritic cell-associated osteopontin in lymphoid follicle pathology and repair and in B cell regulation in HIV-1 and SIV infection
    Qingsheng Li
    Department of Microbiology, University of Minnesota, Minneapolis, MN 55455, USA
    J Infect Dis 192:1269-76. 2005
    ....
  13. ncbi CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract
    Jason M Brenchley
    Human Immunology Section, Vaccine Research Center, National Institutes of Allergy and Infectious Diseases, National Institutes of Health, 40 Convent Dr, Room 3509, Bethesda, MD 20892, USA
    J Exp Med 200:749-59. 2004
    ....
  14. ncbi Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects
    Edwin DeJesus
    Infectious Disease Consultants, Altamonte Springs, Florida 32701, USA
    J Infect Dis 188:1009-16. 2003
    ..There were no episodes of thrombotic microangiopathy. Valacyclovir was safe and effective for the suppression of recurrent genital herpes infection in HIV-infected individuals...
  15. ncbi Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis
    Timothy W Schacker
    Department of Medicine Infectious Diseases, University of Minnesota, MMC 250, 516 Delaware Street, Minneapolis, Minnesota 55455, USA
    J Clin Invest 110:1133-9. 2002
    ....
  16. ncbi Persistent abnormalities in lymphoid tissues of human immunodeficiency virus-infected patients successfully treated with highly active antiretroviral therapy
    Timothy W Schacker
    Department of Medicine, University of Minnesota, MMC 250, 516 Delaware Street, Minneapolis MN 55455, USA
    J Infect Dis 186:1092-7. 2002
    ....
  17. ncbi Imiquimod 5-percent cream does not alter the natural history of recurrent herpes genitalis: a phase II, randomized, double-blind, placebo-controlled study
    Timothy W Schacker
    University of Minnesota, Minneapolis 55455, USA
    Antimicrob Agents Chemother 46:3243-8. 2002
    ....
  18. ncbi Concentration-controlled compared with conventional antiretroviral therapy for HIV infection
    Courtney V Fletcher
    Department of Experimental and Clinical Pharmacology, University of Minnesota Academic Health Sciences Center, Minneapolis, MN, USA
    AIDS 16:551-60. 2002
    ..To demonstrate the feasibility of a concentration-controlled approach to combination antiretroviral therapy, and to compare the virological responses and safety of this strategy versus conventional fixed-dose therapy...
  19. ncbi Collagen deposition limits immune reconstitution in the gut
    Jacob Estes
    Department of Medicine, University of Minnesota, Minneapolis, Minnesota 55455, USA
    J Infect Dis 198:456-64. 2008
    ....
  20. ncbi Ex vivo modeling of oral HIV transmission in human palatine tonsil
    Diane M Maher
    Department of Microbiology, MMC 196, University of Minnesota, 420 Delaware Street SE, Minneapolis, MN 55455, USA
    J Histochem Cytochem 53:631-42. 2005
    ....
  21. ncbi Inguinal lymph node biopsy in patients infected with the human immunodeficiency virus is safe
    David E Skarda
    Department of Surgery, University of Minnesota, Minneapolis, MN 55455, USA
    Surg Infect (Larchmt) 8:173-8. 2007
    ..Additionally, we monitored the rates of other complications, namely, hematoma, dorsal vein thrombosis, epididymitis, lymphocele, and suture extrusion...
  22. ncbi Accuracy of herpes simplex virus detection in liquid-based (SurePath) Papanicolaou tests: a comparison with polymerase chain reaction
    Deniz L Aslan
    Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Fairview University Medical Center, 420 Delaware Street SE, Minneapolis, MN 55455, USA
    Diagn Cytopathol 36:94-103. 2008
    ..Real-time PCR was positive in 8 of 8 cases diagnosed as HSV and none of the 32 controls. We conclude that LBPT allows an increased detection of HSV that is highly accurate...